The intraosseous infusion devices market size is projected to be valued at USD 4.4 billion in 2023 and is expected to rise to USD 8.6 billion by 2033.
The sales of intraosseous infusion devices are expected to grow at a significant CAGR of 6.9% during the forecast period. Various factors propelling the demand for intraosseous infusion devices are:
| Attributes | Details |
|---|---|
| Intraosseous Infusion Devices Market CAGR | 6.9% |
| Intraosseous Infusion Devices Market Valuation (2023) | USD 4.4 billion |
| Intraosseous Infusion Devices Market Valuation (2033) | USD 8.6 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Emergency medical care is considered as pre-hospital or ambulatory transportation aid for road accident victims and those who have sustained life-threatening injuries for which, immediate medical intervention is required. The lack of structural models in medical aid leads to ineffective medical care.
These factors, along with the rising number of emergency cases globally are expected to raise demand for efficient emergency medical services and in turn, are underpinning the intraosseous infusion device market.
According to the American Heart Association report, 2015, compiled with data from the Centers for Disease Control and Prevention, the National Institutes of Health, and other government sources, cardiovascular disease is the leading cause of death globally, associated with 17.3 million deaths per year, which is further expected to increase to 23.6 million by 2030 end.
Vascular access products fill an important void in emergency medical services and contribute significantly towards the annual revenue of various major medical device manufacturers. The ease and immediate effect through vascular access have helped considerably high number of patients requiring immediate medication intervention.
According to an Elsevier/Journal of Emergency Medical Services (JEMS) editorial supplement sponsored by VidaCare, IO infusion supported vascular access to drugs positively and provided rapid vascular access in 250 patients with a success rate of 97%. The study supports the significance of the need for vascular access and is expected to favor the growth of the intraosseous infusion market shortly
Over recent years, there has been a significant upsurge in the number of emergency medical cases in response to rising demand from patients, physicians, and insurers. Rapid technological advancements have led to various medical procedures being carried out using vascular access devices.
According to Future Market Insights (FMI), the sales of the intraosseous infusion device have grown at a CAGR of nearly 7.2% between 2017 and 2022. Increasing research on emergency medical care portfolios globally will result in impressive sales prospects over the coming years.
According to FMI, the intraosseous infusion devices market holds nearly 19% of the USD 18.5 billion worth global market for infusion devices. The demand for intraosseous devices will continue increasing through the forecast period.
For instance, air support for immediate medical emergency services is the new outlook in 911 services and has been appreciated by other emergency health professionals and the local population.
The upcoming air emergency medical service is to be equipped with a variety of emergency medical devices such as a ventilator, cardiac monitor, burn packs, IV pumps, cervical collars, and obstetric kit along with intraosseous infusion devices.
The upcoming policy is expected to drive the intraosseous infusion devices market. Infusion of drugs through the bone using intraosseous devices is more cost effective and can be done more efficiently as compared to intravenous catheters in hospital settings.
Manufacturers are investing in research and development activities to develop IO devices that can be used in hospital settings to initiate instant care to patients. Mergers and acquisitions together with extensive R&D initiatives for strengthening product portfolios are key strategies adopted by companies to increase their revenue.
For Instance, On Dec 18, Cook Medical Incorporated announced the acquisition of Whitaker Park Development Authority Inc. once manufactured cigarettes but henceforth will be manufacturing intraosseous infusion devices for better care of the patients.
The market is consolidated and is dominated by players such as include, Pyng Medical Corp., Cook Medical Incorporated, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Becton Dickinson and Co.
Future Market Insights expects the global market for intraosseous infusion devices to grow at a CAGR of 6.9% between 2023 and 2033. The growth is attributable to the rising number of research and development activities undertaken by market players to expand their presence and strengthen product portfolios.
Principal Consultant
There are two components involved in community care, care during transportation and care in the healthcare facility. In emergency medical departments a patient can be brought in with a severe life-threatening condition, be it severe burns, road traffic accidents, or cardiac arrest, where sometimes it is difficult to find an IV point or it becomes difficult when the venous system is collapsed. This in turn is the need for intraosseous infusion devices in the market.
A rising number of traumatic surgeries especially in pediatric patients has been reported in the past few decades, which is further expected to support the intraosseous infusion devices-based market growth.
According to the Royal College of Surgeons, 2014, a document on emergency surgery policy briefing states that approximately 25% of patients were admitted in an emergency from 2012 to 2013 with 32% of trauma and orthopedic surgery collectively. The rate of patient readmission increased by 27.1% from 2002 to 03 to reach 11.5% in 2012 to 13
The American College of Surgeons Advanced Trauma Life Support Manual (ATLS) 1997, has suggested the use of intraosseous infusion in children up to 6 years of age during traumatic situations like a circulatory failure or after two failed attempts of intravenous access.
Due to the increasing use of I.O., North America was identified as the leading geographical region with a market size of USD 1.2 billion in the intraosseous devices market with the USA being its front-runner.
The rising prevalence of various chronic diseases, the increasing number of traumatic surgeries, and high military consumption, particularly during wartime are pushing the market towards a growth trajectory.
Germany is expected to grow at a rate of 6.3% over the period of 2023-2033. This is due to the increasing aging population, rising cases of chronic diseases, and the presence of well-established centers which provide quality care. Furthermore, favorable regulatory scenarios are likely to offer exciting opportunities for the intraosseous infusion device in Germany.
The Asia Pacific market is expected to account for over 34% of the market share through the forecast period. The increasing use of IO Devices, with advancements in technology, expansion of the healthcare industry, and the rising need for efficient and safe healthcare practices and other therapeutics are the primary factors driving growth in China.
Sales in China are also influenced by domestic market impact factors such as regulatory change, favorable government policies, and growing funding which affect current and future market trends.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In terms of product, EZ-IO intraosseous infusion devices hold the maximum share of over 20% in 2021, expanding at 6.4% CAGR during the forecast period. The growth registered in this category is due to its quick response and surety of easy intraosseous accessibility within 30 seconds.
In terms of route of administration, the Sternum segment accounts for 30.8% of the market share in 2021, indicating the prevalence of high demand for high-quality care specificity when compared with the Distal & Proximal Tibia. This trend is expected to continue during the forecast period as well.
By technology, the automatic infusion devices market accounts for 50.8% of the market share in 2021, expanding at a rate of 6.00%. The demand in this segment will continue to rise. It is primarily preferred by patients when they need instant care.
By end user, EMS and hospitals together will account for more than 60.0% of the market share in 2021. The rising demand for IO devices with various advancements and harnessing new scientific advances is likely to fuel the segment.
Companies that manufacture intraosseous infusion devices are actively seeking to strengthen their position through various strategic planning initiatives such as collaborations, merger and acquisition partnerships, FDA approvals, and agreements with both established and emerging market players.
These strategies will assist manufacturers in capitalizing on market opportunities. The greater the demand for active service, the stronger the end product, resulting in increased market demand.
Leading industry players are concentrating their efforts on the creation and launch of a technologically advanced service portfolio. There are numerous opportunities for market participants to invest in intraosseous infusion devices.
Aero Healthcare acquired Clayton First Aid in July 2020, opening the door for them to expand into intraosseous infusion devices.
Cook Medicals: Every medical discipline we support shares two fundamental themes: patients who want to get healthier and clinicians who want easier-to-use tools. For this reason, we put a lot of effort into developing, producing, and providing a distinctive portfolio of minimally invasive medical devices to healthcare systems all over the world.
Becton Dickinson and Company: With a product range that meets patients' demands, we seek to raise physician satisfaction while helping hospitals and surgery centers improve results and cut costs. For more than a century, BD has advanced surgical instrumentation and contributed to bettering outcomes. with a sizable portfolio and a track record for providing products of the highest caliber.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD billion for Value |
| Key Countries Covered | The USA, Canada, Germany, The United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa |
| Key Segments Covered | By Product, By Route of Administration, By Technology, By End User, Region |
| Key Companies Profiled | Pyng Medical Corp.; Biopsybell; Cook Medical Incorporated; PAVmed; PerSys Medical; Aero Healthcare; Teleflex, Inc.; Becton Dickinson and Company; SAM Medical; Cardinal Health, Inc. |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The Intraosseous Infusion Devices market is predicted to grow at 6.9% CAGR from 2023 to 2033.
High prevalence of chronic diseases and growing geriatric population
The Intraosseous Infusion Devices market is expected to surpass USD 8.6 billion by 2033.
The Intraosseous Infusion Devices market size is anticipated to be USD 4.4 billion in 2023.
1. Executive Summary | Intraosseous Infusion Devices Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 5.1. B.I.G. 5.2. FAST1 5.3. EZ-IO 5.4. FASTR 5.5. IO Needles 5.6. Others 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Route of Administration 6.1. Sternum 6.2. Distal & Proximal Tibia 6.3. Distal Femur 6.4. Calcaneus 6.5. Head of Humerus 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technology 7.1. Manual 7.2. Automatic 7.2.1. Impact Driven 7.2.2. Power Drill 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 8.1. EMS 8.2. Hospitals 8.3. Ambulatory Surgical Centers 8.4. Cardiac Care Centers 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. Asia Pacific excluding Japan (APEJ) 9.6. Japan 9.7. Middle East and Africa (MEA) 10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14. APEJ Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 15. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 16. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 17. Key Countries Market Analysis 18. Market Structure Analysis 19. Competition Analysis 19.1. Pyng Medical Corp. 19.2. Cook Medical Incorporated 19.3. PerSys Medical 19.4. Aero Healthcare 19.5. Teleflex, Inc. 19.6. Becton Dickinson and Co. 19.7. Biopsybell 19.8. Pavmed 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Intraosseous Infusion Devices Market
